Lincoln Pharmaceuticals Announces 32nd AGM on Sep 30, 2026
Lincoln Pharmaceuticals Limited will hold its 32nd Annual General Meeting on September 30, 2026, at 11:00 a.m. IST. The meeting will be conducted via Video Conferencing/Other Audio-Visual Means. Newspaper advertisements regarding the AGM have been published.
The announcement is a standard notification for an upcoming Annual General Meeting, which is a routine corporate procedure. It does not involve any immediate or significant operational, financial, or strategic changes for the company.
The announcement is a routine corporate event notification (AGM) and does not contain any specific financial or operational performance details that would indicate a positive or negative sentiment.
Lincoln Pharmaceuticals Limited has announced its 32nd Annual General Meeting (AGM), scheduled to be held on Wednesday, September 30, 2026, at 11:00 a.m. (IST). The meeting will be conducted through Video Conferencing / Other Audio-Visual Means, in compliance with Ministry of Corporate Affairs Circular No 03/2025 dated September 22, 2025.
The company has published newspaper advertisements regarding the AGM in The Indian Express (Ahmedabad Edition) in English and Financial Express (Ahmedabad Edition) in Gujarati (Vernacular). These advertisements serve as formal notification to the shareholders and stakeholders.
The AGM is a crucial event where shareholders can participate in the company's governance, review performance, and make decisions on important matters. The use of video conferencing ensures broader participation despite geographical limitations.
What to do with a filing like this
Lincoln Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lincoln Pharmaceuticals Limited. Read the original for the full detail.